Anti-BCMA CAR-T Cell Therapy for the R/R Multiple Myeloma
Clinical trial NCT04637269 · UNKNOWN
Trial details
- NCT number
- NCT04637269
- Sponsor
- Xinqiao Hospital of Chongqing
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-17
- Primary completion
- 2021-11-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.